Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model

Circulation Journal

Volumn 70, Issue 4, 2006, Pages 471-477

  Shao, Zhan Qiang ^a   Takaji, Kentaro ^a   Katayama, Yukihiro ^a   Kunitomo, Ryuji ^a   Sakaguchi, Hisashi ^a   Lai, Zhong Fang ^a   Kawasuji, Michio ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Angiogenesis; Apoptosis; Ischemic heart disease; Myocardial remodeling

Indexed keywords

GELATIN; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; SODIUM CHLORIDE;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; HEART INFARCTION; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HYDROGEL; MALE; NONHUMAN; RAT; SLOW RELEASE FORMULATION; TISSUE REGENERATION;

ANIMALS; APOPTOSIS; CAPILLARIES; DELAYED-ACTION PREPARATIONS; ECHOCARDIOGRAPHY; FIBROBLAST GROWTH FACTOR 2; HYDROGELS; MALE; MYOCARDIAL INFARCTION; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, SPRAGUE-DAWLEY; VENTRICULAR FUNCTION; VENTRICULAR REMODELING;

EID: 33645364686     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.471     Document Type: Article

References (25)

1. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000; 6: 389-395.
2. Yanagisawa-Miwa A, Uchida Y, Nakamura F, Tomaru T, Kido H, Kamijo T, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992; 257: 1401-1403.
3. Harada K, Grossman W, Friedman M, Edelman ER, Prasad PV, Keighley CS, et al. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J Clin Invest 1994; 94: 623-630.
4. Kawasuji M, Nagamine H, Ikeda M, Sakakibara N, Takemura H, Fujii S, et al. Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor. Ann Thorac Surg 2000; 69: 1155-1161.
5. Post MJ, Laham R, Sellke FW, Simons M. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc Res 2001; 49: 522-531.
6. Sellke FW, Laham RJ, Edelman ER, Pearlman JD, Simons M. Therapeutic angiogenesis with basic fibroblast growth factor: Technique and early results. Ann Thorac Surg 1998; 65: 1540-1544.
7. Simons M, Bonow RO, Chronos NA, Cohen DJ, Giordano FJ, Hammond HK, et al. Clinical trials in coronary angiogenesis: Issues, problems, consensus: An expert panel summary. Circulation 2000; 102: E73-E86.
8. Park K, Shalaby WS, Park H. Biodegradable drug delivery systems. In: Biodegradable Hydrogels for Drug Delivery. 1st edn. Pennsylvania: Technomic Publishing; 1993; 189-223.
9. Tabata Y, Hijikata S, Ikada Y. Enhanced vascularization and tissue granulation by basic fibroblast growth factor impregnated in gelatin hydrogels. J Control Release 1994; 31: 189-199.
10. Brooks WW, Bing OH, Robinson KG, Slawsky MT, Chaletsky DM, Conrad CH. Effect of angiotensin-converting enzyme inhibition on myocardial fibrosis and function in hypertrophied and failing myocardium from the spontaneously hypertensive rat. Circulation 1997; 96: 4002-4010.
11. Alhaddad IA, Tkaczevski L, Siddiqui F, Mir R, Brown EJ Jr. Aspirin enhances the benefits of late reperfusion on infarct shape: A possible mechanism of the beneficial effects of aspirin on survival after acute myocardial infarction. Circulation 1995; 91: 2819-2823.
12. Sasaki H, Ray PS, Zhu L, Otani H, Asahara T, Maulik N. Hypoxia/reoxygenation promotes myocardial angiogenesis via an NF kappa B-dependent mechanism in a rat model of chronic myocardial infarction. J Mol Cell Cardiol 2001; 33: 283-294.
13. Min JY, Yang Y, Sullivan MF, Ke Q, Converso KL, Chen Y, et al. Long-term improvement of cardiac function in rats after infarction by transplantation of embryonic stem cells. J Thorac Cardiovasc Surg 2003; 125: 361-369.
14. Palojoki E, Saraste A, Eriksson A, Pulkki K, Kallajoki M, Voipio-Pulkki LM, et al. Cardiomyocyte apoptosis and ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 2001; 280: H2726-H2731.
15. Simons M, Annex BH, Laham RJ, Kleiman N, Henry T, Dauerman H, et al. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial. Circulation 2002; 105: 788-793.
16. Iwakura A, Fujita M, Kataoka K, Tambara K, Sakakibara Y, Komeda M, et al. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels 2003; 18: 93-99.
17. Fukuhara S, Tomita S, Nakatani T, Fujisato T, Ohtsu Y, Ishida M, et al. Bone marrow cell-seeded biodegradable polymeric scaffold enhances angiogenesis and improves function of the infarcted heart. Circ J 2005; 69: 850-857.
18. Ren G, Michael LH, Entman ML, Frangogiannis NG. Morphological characteristics of the microvasculature in healing myocardial infarcts. J Histochem Cytochem 2002; 50: 71-79.
19. Frangogiannis NG, Smith CW, Entman ML. The inflammatory response in myocardial infarction. Cardiovasc Res 2002; 53: 31-47.
20. Swynghedauw B. Molecular mechanisms of myocardial remodeling. Physiol Rev 1999; 79: 215-262.
21. Sharov VG, Sabbah HN, Shimoyama H, Goussev AV, Lesch M, Goldstein S. Evidence of cardiocyte apoptosis in myocardium dogs with chronic heart failure. Am J Pathol 1996; 148: 141-149.
22. Iwai-Kanai E, Hasegawa K, Fujita M, Araki M, Yanazume T, Adachi S, et al. Basic fibroblast growth factor protects cardiac myocytes from iNOS-mediated apoptosis. J Cell Physiol 2002; 190: 54-62.
23. Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18: 26-45.
24. Ju H, Hao J, Zhao S, Dixon IM. Antiproliferative and antifibrotic effects of mimosine on adult cardiac fibroblasts. Biochim Biophys Acta 1998; 1448: 51-60.
25. Kobayashi S, Kawashima S, Sakoda T, Ueyama T, Hirase T, Kawai M, et al. Glycogen synthase kinase-3 is involved in the process of myocardial hypertrophy stimulated by insulin-like growth factor-1. Circ J 2004; 68: 247-253.